Genus PLC (GNS.L)
Latest Key Developments (Source: Significant Developments)
May 16 (Reuters) - Genus PLC
Nov 16 (Reuters) - Genus Plc
Rallying banks and mining stocks lifted Britain's FTSE 100 on Thursday, but weak earnings hit luxury brand Burberry and Thomas Cook was floored by a profit warning.
- 3 Healthcare Stocks With More Downside Than Upside? Shire PLC, Alliance Pharma plc And Genus plc
- AstraZeneca plc, Smith & Nephew plc And Genus plc: Buy, Sell Or Hold?
- GlaxoSmithKline plc, Genus plc And Alliance Pharma plc: 3 Of The Best Health Care Stocks?
- Does Sepura Plc Offer More Value Than Genus plc & SDL plc After A 24% Rally?
- Is AstraZeneca plc A Better Buy Than BTG plc, Dechra Pharmaceuticals plc And Genus plc?
- Are Genus plc And Dechra Pharmaceuticals plc Better Buys Than GlaxoSmithKline plc?